PTC Therapeutics, Inc. (PTCT)
68.95
+1.18
(+1.74%)
USD |
NASDAQ |
Apr 06, 16:00
68.95
0.00 (0.00%)
After-Hours: 16:11
PTC Therapeutics SG&A Expense (TTM) : 347.14M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Insmed, Inc. | 701.17M |
| Sarepta Therapeutics, Inc. | 491.72M |
| Keros Therapeutics, Inc. | 46.85M |
| Madrigal Pharmaceuticals, Inc. | 813.83M |
| Protagonist Therapeutics, Inc. | 44.85M |